GeneDx Appoints Cunningham to Succeed Stueland
GeneDx appointed Everett Cunningham CEO and director effective when he starts, expected by December 15, 2026. Katherine Stueland will leave both roles at that point and remain an executive adviser through January 31, 2027….




